Full name
URSAPHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
URSAPHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WYBRZEŻE GDYŃSKIE 27, 01-531 WARSZAWA
TAX ID1182030124
Rate company:
URSAPHARM POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1182030124
KRS0000358065
Share capital50,000.00 zł
address
UL. WYBRZEŻE GDYŃSKIE 27, 01-531 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1182030124
REGON
142357479
KRS
0000358065
Legal form
limited liability company
Register Address
UL. WYBRZEŻE GDYŃSKIE 27, 01-531 WARSZAWA
Date of registration in KRS
2010-06-15
Date of commencement of economic activity
2010-06-15
Act signature
WA.XIV NS-REJ.KRS/50561/24/881/ADE
Pkd codes
46.46.Z - Wholesale trade of pharmaceutical and medical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.45.Z - Wholesale trade of perfumes and cosmetics
63.99.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
73.11.Z - Advertising agency activities
85.60.Z - Educational support activities
Payer VAT status
Active
Vat list bank account(s)
PL17 1140 1010 0000 5317 2800 1001 
PL87 1140 1010 0000 5317 2800 1002 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 10,4 | -1,8 | 4,2 | 331,2 |
EBITDA | 10,5 | -1,8 | 4,2 | 336,3 |
Short time liabilities | 2,2 | 2,9 | 1,2 | -59,2 |
Equity capital | 36,9 | 24,6 | 23,8 | -3,4 |
Operating profit (EBIT) | 10,4 | -1,8 | 4,1 | 329,2 |
Assets | 40,1 | 28,3 | 26,3 | -7,4 |
Net profit (loss) | 8,4 | -1,8 | 3,4 | 288,6 |
Cash | 16,3 | 3,9 | 7,2 | 85,4 |
Liabilities and provisions for liabilities | 3,2 | 3,7 | 2,5 | -33,5 |
Net income from sale | 53,9 | 28,7 | 40,1 | 40 |
Working assets | 40 | 28,1 | 26,1 | -7,3 |
Depreciation | 0,1 | 0 | 0,1 | 67,7 |
% | % | % | p.p. | |
Profitability of capital | 22,8 | -7,4 | 14,4 | 21,8 |
Equity capital to total assets | 92,1 | 86,8 | 90,5 | 3,7 |
Gross profit margin | 19,3 | -6,3 | 10,4 | 16,7 |
EBITDA Margin | 19,5 | -6,2 | 10,5 | 16,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 15 | 37 | 11 | -26 |
Current financial liquidity indicator | 12.59020709991455 | 7.526181221008301 | 10.83369255065918 | 3,3 |
Net dept to EBITDA | -1.5512975454330444 | 2.1827728748321533 | -1.712546467781067 | -3,9 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
"FARMEDICA" sp. z o.o.
Warszawa
CMS Polska sp. z o.o.
Rzeszów
Gama Sp. z o.o.
Ruda Śląska
"SOLINEA" sp. z o.o. sp.k.
Ciecierzyn
Red Med Poland Sp. z o.o.
Chorzów
DKR Medical sp. z o.o.
Poznań